PAREXEL International (India)

PAREXEL International (India)

Parexel is an American contract research organization. It conducts clinical trials on behalf of its pharmaceutical and biotechnology clients to expedite drug development and clinical trial progress. It is one of the largest clinical research organizations in the world. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for PAREXEL International (India), India, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

71%


Total
Publications

240


Total Open
Publications

170


Total
Citations

1.8K


Open Access
Percentage

71%


Total
Publications

240


Total Open
Publications

170


Total
Citations

1.8K

Wikipedia

Website

download

Breakdown

55% 13% 3% 29%

Publisher Open

55%

Both

13%

Other Platform Open

3%

Closed

29%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0510152025303540Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

18%OA Journal

OA Journal 18%

29

Hybrid 65%

105

No Guarantees 17%

28

Other Platform Open

Domain 82%

31

Institution 26%

10

Other Internet 16%

6

Public 8%

3

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
31
Europe PMC
Domain
9
Coventry University - Pure
Institution
5
University College London - UCL Discovery
Institution
4
Taylor and Francis Group - Dove Medical Press
Other Internet
3
DOI
Other Internet
3
Unknown Repository
Other Internet
2
Semantic Scholar
Public
2
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes
Institution
2
Le Centre pour la Communication Scientifique Directe - HAL - Université de Nantes
Institution
2
1 / 2

Data updated 7 April 2025

Share

Share

Share